Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. The European ...

Shares of Teva Pharmaceutical (NYSE:TEVA) gained in the premarket trading on Wednesday after the generic drugmaker reported better-than-expected Q3 2024 financials and raised its full-year outlook ...

Wednesday, Teva revealed booming third-quarter sales for its generics and biosimilars. In the U.S., revenue from the knockoffs came in at $1.1 billion, which was a 30% increase year over year, or ...

Teva Hit With €463 Million EU Fine for Talking Down Rivals EU says Israeli firm thwarted competition for MS drug Teva vows to appeal decision, says it is ‘deeply dissapointed’ ...

European Union antitrust authorities fined Israel’s Teva Pharmaceuticals TEVA-0.99%decrease; red down pointing triangle 462.6 million euros ($502.3 million), saying the company abused its market ...

Immunai Inc., an artificial intelligence biotechnology company, announced on Thursday a multi-year collaboration in immunology and immuno-oncology programs with Teva Pharmaceuticals. Immunology is ...

To do that, Teva conducted a "disparagement campaign" against Synthon, the only other company with an authorised drug in Europe containing glatiramer acetate, the Commission said in a statement.

The best shoe racks—including our top pick, Yamazaki Home Tower Six-Tier Shoe Rack—store multiple pairs without wasting precious floor space, are sturdy and resilient, and ideally, attractive ...

TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the ...